NovaBay Pharmaceuticals to Hold Third Quarter 2022 Conference Call on November 14
09 Novembre 2022 - 10:05PM
Business Wire
NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces
that it will report financial results for the three and nine months
ended September 30, 2022 after market close on Monday, November 14,
2022 and will hold an investment community conference call that day
beginning at 4:30 p.m. Eastern time.
Date/Time:
Monday, November 14, 4:30 p.m. ET / 1:30
p.m. PT
Pre-Registration:
Participants can pre-register for the
conference call here:
Callers who pre-register will be given a
conference passcode and unique PIN to gain immediate access to the
call and bypass the live operator. Participants may pre-register at
any time, including up to and after the call start time.
Dial In:
Those who choose not to pre-register can
access the live conference call by dialing the following and
requesting the NovaBay Pharmaceuticals call:
866-777-2509 from within the U.S.
412-317-5413 from outside the U.S.
The live webcast of the conference call also will be available
at https://investors.novabay.com/events/. A replay of the call will
be available beginning two hours after its completion through
December 5, 2022 by dialing 877-344-7529 from within the U.S.,
855-669-9658 from Canada or 412-317-0088 from outside the U.S., and
entering conference ID 1836583. The webcast will also be archived
at https://investors.novabay.com/events/.
About NovaBay Pharmaceuticals, Inc.:
NovaBay Pharmaceuticals, Inc. develops and sells
problem-solving, accessible solutions for improved well-being in
the eyecare, skincare, and wound care markets. NovaBay’s leading
product, Avenova® Antimicrobial Lid & Lash Solution, is often
prescribed by eyecare professionals for blepharitis and dry-eye
disease and is also available directly to eyecare consumers through
online distribution channels such as Amazon. DERMAdoctor® offers
more than 30 OTC dermatologist-developed skincare products through
the DERMAdoctor website, well-known traditional and digital beauty
retailers, and international distributors. NovaBay also
manufactures and sells effective, yet gentle and non-irritating
wound care products. The PhaseOne® brand is distributed through
commercial partners in the U.S. for professional use only, and the
NeutroPhase® brand is distributed in China by Pioneer Pharma (Hong
Kong) Company Ltd.
Socialize and Stay Informed on
NovaBay’s Progress Like us on Facebook Follow us on
Twitter Connect with NovaBay on LinkedIn Visit NovaBay’s
Website
Avenova Purchasing
Information For NovaBay Avenova purchasing information:
Please call 800-890-0329 or email sales@avenova.com Avenova.com
DERMAdoctor Purchasing
Information For DERMAdoctor purchasing information:
Please call 877-337-6237 or email service@dermadoctor.com
DERMAdoctor.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221109005961/en/
NovaBay Contact Justin Hall
Chief Executive Officer and General Counsel 510-899-8800
jhall@novabay.com
Investor Contact LHA
Investor Relations Jody Cain 310-691-7100 jcain@lhai.com
NovaBay Pharmaceuticals (AMEX:NBY)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024
NovaBay Pharmaceuticals (AMEX:NBY)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024